HEAD & NECK SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD & NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD & NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD & NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for head and neck cancer patients who Can't take chemo
Disease control Recruiting nowThis study tests a new treatment for people with high-risk head and neck cancer who cannot receive the standard chemotherapy drug cisplatin. After surgery, patients receive radiation therapy combined with a targeted drug (nimotuzumab), followed by an immunotherapy drug (benmelsto…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated May 17, 2026 03:27 UTC
-
New combo therapy aims to improve outcomes for head and neck cancer patients
Disease control Recruiting nowThis study tests whether adding the targeted drug nimotuzumab to standard radiation therapy helps control advanced head and neck cancer better than radiation alone. It is for 335 adults whose cancer has spread locally but cannot have platinum chemotherapy. The main goal is to see…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a simple supplement tame Immunotherapy's side effects in head and neck cancer?
Disease control Recruiting nowThis study is for people with advanced head and neck cancer who are starting a standard immunotherapy drug called pembrolizumab. Researchers want to see if adding a special supplement (postbiotic) can reduce the immune-related side effects of the drug. About 45 participants will …
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
New PET scan could end guesswork for head & neck cancer patients after radiation
Diagnosis Recruiting nowThis study tests a new, more detailed PET scan to see if it can tell the difference between cancer that is still there and normal swelling after radiation treatment. 180 adults with head and neck cancer will get this scan 3 months after finishing radiation. The goal is to help do…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated May 17, 2026 03:29 UTC
-
Smart radiotherapy aims to slash swallowing and dry mouth side effects
Symptom relief Recruiting nowThis study tests a new way to give radiation for head and neck cancer that adjusts each day to changes in the patient's anatomy. The goal is to lower radiation to healthy organs and reduce side effects like trouble swallowing and dry mouth. About 40 adults with throat or voice bo…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
PET scans may predict immunotherapy success in head and neck cancer
Knowledge-focused Recruiting nowThis study looks at whether a special PET scan taken 6 weeks after starting immunotherapy can predict how well the treatment will work later. It involves 25 adults with advanced head and neck cancer who are starting a drug called pembrolizumab. The goal is to see if early changes…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated May 17, 2026 03:23 UTC